A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer

NCT01784120 ·Status: UNKNOWN ·Phase: PHASE2

Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer

NCT01352494 ·Status: UNKNOWN ·Phase: PHASE2

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

NCT06452394 ·Status: RECRUITING ·Phase: PHASE2

Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients

NCT00270894 ·Status: COMPLETED ·Phase: PHASE2

Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

NCT00645866 ·Status: COMPLETED ·Phase: PHASE2

Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk Score

NCT02236572 ·Status: TERMINATED ·Phase: PHASE2

Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer

NCT01229605 ·Status: WITHDRAWN ·Phase: PHASE2

Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

NCT04881929 ·Status: UNKNOWN ·Phase: PHASE2

Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy

NCT05069038 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

NCT01319539 ·Status: TERMINATED ·Phase: PHASE2

Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer

NCT00193206 ·Status: COMPLETED ·Phase: PHASE2

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

NCT00425672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

NCT02101385 ·Status: COMPLETED ·Phase: PHASE2

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

NCT05846789 ·Status: RECRUITING ·Phase: PHASE2

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

NCT03939481 ·Status: ACTIVE_NOT_RECRUITING

Ceramide Cream in Treating Women With Cutaneous Breast Cancer

NCT00008320 ·Status: COMPLETED ·Phase: PHASE2

Gene Expression Profiling and Genetic Analysis of Tissues From Patients With Breast Cancer

NCT00899509 ·Status: COMPLETED

Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery

NCT03317405 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Regional Cryotherapy in Preventing Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

NCT03429972 ·Status: UNKNOWN ·Phase: PHASE2

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

NCT00665457 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

NCT00002866 ·Status: COMPLETED ·Phase: PHASE1

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

NCT00832338 ·Status: TERMINATED ·Phase: PHASE2

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

NCT00268918 ·Status: COMPLETED ·Phase: PHASE1

Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer

NCT01479036 ·Status: UNKNOWN ·Phase: PHASE3

An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer

NCT01660542 ·Status: COMPLETED ·Phase: PHASE4